These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 26641029)

  • 1. Iron-Oxide-Based Nanovector for Tumor Targeted siRNA Delivery in an Orthotopic Hepatocellular Carcinoma Xenograft Mouse Model.
    Wang K; Kievit FM; Sham JG; Jeon M; Stephen ZR; Bakthavatsalam A; Park JO; Zhang M
    Small; 2016 Jan; 12(4):477-87. PubMed ID: 26641029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Glypican-3 in the growth, migration and invasion of primary hepatocytes isolated from patients with hepatocellular carcinoma.
    Montalbano M; Rastellini C; McGuire JT; Prajapati J; Shirafkan A; Vento R; Cicalese L
    Cell Oncol (Dordr); 2018 Apr; 41(2):169-184. PubMed ID: 29204978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipidation of polyethylenimine-based polyplex increases serum stability of bioengineered RNAi agents and offers more consistent tumoral gene knockdown in vivo.
    Zhang QY; Ho PY; Tu MJ; Jilek JL; Chen QX; Zeng S; Yu AM
    Int J Pharm; 2018 Aug; 547(1-2):537-544. PubMed ID: 29894758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Superparamagnetic iron oxide nanoparticles modified with polyethylenimine and galactose for siRNA targeted delivery in hepatocellular carcinoma therapy.
    Yang Z; Duan J; Wang J; Liu Q; Shang R; Yang X; Lu P; Xia C; Wang L; Dou K
    Int J Nanomedicine; 2018; 13():1851-1865. PubMed ID: 29618926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-Alkyl-PEI-functionalized iron oxide nanoclusters for efficient siRNA delivery.
    Liu G; Xie J; Zhang F; Wang Z; Luo K; Zhu L; Quan Q; Niu G; Lee S; Ai H; Chen X
    Small; 2011 Oct; 7(19):2742-9. PubMed ID: 21861295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chlorotoxin bound magnetic nanovector tailored for cancer cell targeting, imaging, and siRNA delivery.
    Veiseh O; Kievit FM; Fang C; Mu N; Jana S; Leung MC; Mok H; Ellenbogen RG; Park JO; Zhang M
    Biomaterials; 2010 Nov; 31(31):8032-42. PubMed ID: 20673683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of glypican 3 inhibits growth of hepatocellular carcinoma cells through up-regulation of TGF-β2.
    Sun CK; Chua MS; He J; So SK
    Neoplasia; 2011 Aug; 13(8):735-47. PubMed ID: 21847365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and
    Ma XH; Wang S; Liu SY; Chen K; Wu ZY; Li DF; Mi YT; Hu LB; Chen ZW; Zhao XM
    World J Gastroenterol; 2019 Jun; 25(24):3030-3043. PubMed ID: 31293339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of hybrid-type modified chitosan derivative nanoparticles for the intracellular delivery of midkine-siRNA in hepatocellular carcinoma cells.
    Zhong J; Huang HL; Li J; Qian FC; Li LQ; Niu PP; Dai LC
    Hepatobiliary Pancreat Dis Int; 2015 Feb; 14(1):82-9. PubMed ID: 25655295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanoparticles for targeted delivery of therapeutics and small interfering RNAs in hepatocellular carcinoma.
    Varshosaz J; Farzan M
    World J Gastroenterol; 2015 Nov; 21(42):12022-41. PubMed ID: 26576089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-GPC3 antibody-modified sorafenib-loaded nanoparticles significantly inhibited HepG2 hepatocellular carcinoma.
    Tang X; Chen L; Li A; Cai S; Zhang Y; Liu X; Jiang Z; Liu X; Liang Y; Ma D
    Drug Deliv; 2018 Nov; 25(1):1484-1494. PubMed ID: 29916268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiofluorinated GPC3-Binding Peptides for PET Imaging of Hepatocellular Carcinoma.
    Li Y; Zhang J; Gu J; Hu K; Huang S; Conti PS; Wu H; Chen K
    Mol Imaging Biol; 2020 Feb; 22(1):134-143. PubMed ID: 31044341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glypican-3-Targeted
    Labadie KP; Hamlin DK; Kenoyer A; Daniel SK; Utria AF; Ludwig AD; Kenerson HL; Li L; Sham JG; Chen DL; Orozco JJ; Yeung RS; Orvig C; Li Y; Wilbur DS; Park JO
    J Nucl Med; 2022 Jul; 63(7):1033-1038. PubMed ID: 34772791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation of magnetic resonance probes using one-pot method for detection of hepatocellular carcinoma.
    Li YW; Chen ZG; Zhao ZS; Li HL; Wang JC; Zhang ZM
    World J Gastroenterol; 2015 Apr; 21(14):4275-83. PubMed ID: 25892879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A GPC3-specific aptamer-mediated magnetic resonance probe for hepatocellular carcinoma.
    Zhao M; Liu Z; Dong L; Zhou H; Yang S; Wu W; Lin J
    Int J Nanomedicine; 2018; 13():4433-4443. PubMed ID: 30122918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T Cells Engineered to Express a T-Cell Receptor Specific for Glypican-3 to Recognize and Kill Hepatoma Cells In Vitro and in Mice.
    Dargel C; Bassani-Sternberg M; Hasreiter J; Zani F; Bockmann JH; Thiele F; Bohne F; Wisskirchen K; Wilde S; Sprinzl MF; Schendel DJ; Krackhardt AM; Uckert W; Wohlleber D; Schiemann M; Stemmer K; Heikenwälder M; Busch DH; Richter G; Mann M; Protzer U
    Gastroenterology; 2015 Oct; 149(4):1042-52. PubMed ID: 26052074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of glypican-3 expression via RNA interference influences the growth and invasive ability of the MHCC97-H human hepatocellular carcinoma cell line.
    Ruan J; Liu F; Chen X; Zhao P; Su N; Xie G; Chen J; Zheng D; Luo R
    Int J Mol Med; 2011 Oct; 28(4):497-503. PubMed ID: 21617840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of T cells redirected to glypican-3 for the treatment of hepatocellular carcinoma.
    Gao H; Li K; Tu H; Pan X; Jiang H; Shi B; Kong J; Wang H; Yang S; Gu J; Li Z
    Clin Cancer Res; 2014 Dec; 20(24):6418-28. PubMed ID: 25320357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. pH-Sensitive siRNA nanovector for targeted gene silencing and cytotoxic effect in cancer cells.
    Mok H; Veiseh O; Fang C; Kievit FM; Wang FY; Park JO; Zhang M
    Mol Pharm; 2010 Dec; 7(6):1930-9. PubMed ID: 20722417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Superparamagnetic iron oxide nanoparticles mediated (131)I-hVEGF siRNA inhibits hepatocellular carcinoma tumor growth in nude mice.
    Chen J; Zhu S; Tong L; Li J; Chen F; Han Y; Zhao M; Xiong W
    BMC Cancer; 2014 Feb; 14():114. PubMed ID: 24555445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.